Patients were recruited from eight Birmingham and three Lambeth practices from November 2005 to November 2008. The cohort was formed from patients with at least one abnormal analyte (from a panel of ...

Doctors can diagnose fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), using blood tests that measure serum liver enzyme levels. Elevated enzyme levels ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Researchers have developed a tool that uses blood biomarkers to help determine when steatotic liver disease is caused by ...

As the body’s chemical clearinghouse, the liver is prone to drug-induced injury. Detecting liver damage, though, is complicated because the standard protein biomarkers of liver damage are expressed ...

A new combined test panel called Lipid Profile ALT (Cholestech Corp., Hayward, Calif.) has received an FDA waiver from Clinical Laboratory Improvement Amendments (CLIA) standards. The panel, designed ...

Expert clinicians remark on the current role of the liver biopsy in the diagnosis of advanced fibrosis due to nonalcoholic steatohepatitis and highlight considerations for utilizing newer, noninvasive ...

A DNA-based blood panel developed by Exact Sciences and the Mayo Clinic accurately detected liver cancer across all stages of the disease and outperformed the most commonly used serum test in a phase ...

A comprehensive metabolic panel (CMP) is a set of tests that a doctor may order to find out more about a person’s overall health. These are routine tests that can help evaluate how well the body is ...